Acumen Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Acumen Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Acumen Pharmaceuticals Inc
Rating: 1.65608325
Author: Trendlyne DVM scores

about

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

2.38 -0.11 (-4.42%)

33.89% Fall from 52W High

203.4K

XNAS Volume

XNAS 14 May, 2026 3:05 PM (EDT)

Board Meeting

The board meeting for Acumen Pharma Inc is scheduled for today, for the purpose of Bank of America Securities 2026 Health Care Conference See details

Not Eligible

Expensive Valuation

8.8 / 100

Technically Neutral

57.4 / 100

No estimates available

Acumen Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acumen Pharma Inc Live Stock Price Today, Share Analysis and Chart

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass...

33.89% Fall from 52W High

SWOT Analysis

Acumen Pharma Inc Live Price Chart